NDC 62541-503
STENDRA
Avanafil
STENDRA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Vivus Llc. The primary component is Avanafil.
| Product ID | 62541-503_e10a546c-9a9c-1f78-e053-2a95a90a40d3 |
| NDC | 62541-503 |
| Product Type | Human Prescription Drug |
| Proprietary Name | STENDRA |
| Generic Name | Avanafil |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-01-01 |
| Marketing Category | NDA / |
| Application Number | NDA202276 |
| Labeler Name | Vivus LLC |
| Substance Name | AVANAFIL |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 62541-503-30
30 TABLET in 1 BOTTLE (62541-503-30)
| Marketing Start Date | 2022-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
NDC Crossover Matching brand name "STENDRA" or generic name "Avanafil"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 62541-501 | STENDRA | Avanafil |
| 62541-502 | STENDRA | Avanafil |
| 62541-503 | STENDRA | Avanafil |
| 72384-751 | Stendra | avanafil |
| 72384-752 | Stendra | avanafil |
| 72384-753 | Stendra | avanafil |
| 76299-320 | Stendra | avanafil |
| 76299-321 | Stendra | avanafil |
| 76299-322 | Stendra | avanafil |
Trademark Results [STENDRA]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 STENDRA 85565411 4526269 Live/Registered |
METUCHEN PHARMACEUTICALS, LLC 2012-03-09 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.